First use of icatibant (selective bradykinin receptor antagonist) in hereditary angioedema patients in the UK

被引：0
|
作者：
Karanam, S.
Demptser, J.
Longhurst, H.
Gompels, M.
机构：
[1] Southmead Hosp, Bristol, Avon, England
[2] St Bartholomews Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2009年 / 39卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1943 / 1943
页数：1
相关论文
共 50 条
  • [21] Successful treatment of hereditary angioedema with a bradykinin receptor antagonist
    Bork, K
    Meng, G
    Wiest, K
    Grundt, B
    Schneiders, V
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
  • [22] Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema
    Greve, Jens
    Hoffmann, Thomas K.
    Schuler, Patrick
    Lang, Stephan
    Chaker, Adam
    Bas, Murat
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (10) : 1294 - 1295
  • [23] Treatment of Acute Hereditary Angioedema located in the upper aerodigestive tract with Bradykinin-B2-Receptor-Antagonist Icatibant
    Bas, M.
    Greve, J.
    Kojda, G.
    Bier, H.
    Hoffmann, T.
    ALLERGY, 2008, 63 : 348 - 348
  • [24] Safety Evaluation of Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency
    Staubach, P.
    Bork, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S100 - S100
  • [25] Self-administration of a novel subcutaneous bradykinin b2 receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
    Santucci S.
    Pham H.
    Harrison R.
    Yang W.
    Allergy, Asthma & Clinical Immunology, 10 (Suppl 2)
  • [26] Treatment of hereditary angioedema due to C1 inhibitor deficiency with Icatibant, a selective bradykinin B2 receptor antagonist: a safety perspective
    Bork, K.
    ALLERGY, 2008, 63 : 47 - 47
  • [27] Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant
    Del Corso, I.
    Puxeddu, I.
    Sardano, E.
    Geraci, S.
    Breggia, M.
    Rocchi, V.
    Migliorini, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (06) : 460 - 461
  • [28] Successful long term treatment of 141 attacks in a patient with hereditary angioedema with the bradykinin B2 receptor antagonist icatibant
    Greve, J.
    Bas, M.
    Schuler, P.
    Schipper, J.
    Lang, S.
    Hoffmann, T.
    ALLERGY, 2009, 64 : 281 - 281
  • [29] A case series about the treatment of hereditary angioedema due to C1 inhibitor deficiency with icatibant, a selective bradykinin B2 receptor antagonist
    Bork, K.
    ALLERGY, 2010, 65 : 455 - 455
  • [30] Proof-of-concept study of icatibant (JE 049), a bradykinin B2 receptor antagonist in treatment of hereditary angioedema.
    Rosenkranz, B
    Bork, K
    Frank, J
    Kreuz, W
    Dong, L
    Knolle, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P14 - P14
12345